S&P 500

5.537,02

0,51%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

Startseite
Investieren
Aktien
USA
USOTC
IR BioSciences Holdings Inc New (CE) (IRBS)
IR BioSciences Holdings Inc New (CE) (IRBS) News

IRBS

IR BioSciences (CE) (IRBS)

IR BioSciences Holdings Inc New (CE)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:IRBS

1 2 3 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
24/05/2011	23h28	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
16/05/2011	21h11	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
31/03/2011	18h54	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
10/03/2011	23h29	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
22/11/2010	22h12	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
12/11/2010	14h27	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
28/10/2010	15h00	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
01/10/2010	22h37	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
08/09/2010	13h00	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
31/08/2010	20h21	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
25/08/2010	15h00	GlobeNewswire Inc.	University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
23/08/2010	23h15	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
13/08/2010	22h12	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
05/08/2010	14h27	Marketwired	/ CORRECTION - ImmuneRegen BioSciences	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
04/08/2010	13h00	Marketwired	ImmuneRegen BioSciences Completes Successful Reduction of Debt	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
26/07/2010	12h01	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
24/05/2010	21h40	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
17/05/2010	17h51	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
30/04/2010	23h17	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
27/04/2010	14h00	Marketwired	ImmuneRegen BioSciences(R) Announces Collaboration With the Department of Tumor Immunology of the Radboud University Nijmegen Me	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
21/04/2010	14h00	Marketwired	ImmuneRegen BioSciences(R) Initiates Strategic Collaboration With MPI Research to Accelerate Clinical Development of Lead Indica	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
19/04/2010	19h00	Marketwired	ImmuneRegen BioSciences(R) Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
15/04/2010	22h20	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
01/04/2010	22h01	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
04/03/2010	14h00	Marketwired	ImmuneRegen BioSciences Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary Fi	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
10/02/2010	14h00	Marketwired	Fred Hutchinson Cancer Research Center Initiates Studies on ImmuneRegen BioSciences' Cancer Therapy Candidate	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
27/01/2010	14h00	Marketwired	National Cancer Institute Initiates Studies on ImmuneRegen BioSciences' Vaccine Adjuvant Candidate	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
26/01/2010	20h54	Marketwired	IR Biosciences' ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Active Compound	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
05/01/2010	14h00	Marketwired	ImmuneRegen BioSciences(R) Reports Additional Positive Results From Study of Homspera(R) in Treating Highly Pathogenic Influenza	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
24/12/2009	14h00	Marketwired	ImmuneRegen BioSciences(R) Summarizes Previous 9 Months of Advances as Homspera(R) Development Continues	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)